Estroven Complete Multi-Symptom Menopause Relief
Natural health product licensed in Canada
- Licence holder
- i-Health Inc.
- NPN or DIN-HM
- 80116716
- Status
- Active licence
- Licence date
- 24 February 2022
- Revision date
- Not provided
- Form
- Comprimé, libération retardée
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Rheum rhaponticum Source : Rheum rhaponticum - racine Extract : Matériel brut sec Extraction ratio : 16:1 Dry plant equivalent : 64 mg | 4 mg | Not calculated |
| Rheum rhaponticum Source : Rheum rhaponticum - racine Extract : Matériel brut sec Extraction ratio : 26:1 Dry plant equivalent : 104 mg | Not specified | Not calculated |
Non-medicinal ingredients
Alginate de sodium, Stéarate de magnésium, Phosphate dicalcique, Éthylcellulose, Croscarmellose de sodium, Acide oléique, Hydroxyde d'ammonium, Maltodextrine, Cellulose microcristalline, Hypromellose, Riboflavine, Dioxyde de silicium, Poly(dextrose), Dioxyde de titane, NA, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Femmes ménopausées, postménopausées et périmenopausal | minimum: 18 years | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Estroven provides multi symptom Menopause Relief. Clinically proven to help relieve major Menopause Symptoms without raising estrogen levels. Clinically proven to relief of all Major Menopause Symptoms such as hot flashes, night sweats, sleeplessness, low energy, mental & Physical exhaustion, vaginal dryness, mild anxiety, occasional bladder leakage and joint & muscular comfort. Clinically shown to help reduce severe and frequent menopausal symptoms (such as hot flashes/flushes and/or night sweats). Estroven proven effective to help manage severe Menopause Symptoms . Clinically proven to show the effect in as little 28 days for relief of Menopause Symptoms and improvement upon continued use. Estroven helps support healthy mood balance and sexual health during menopause.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80116716
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.